Skip to main content
Clinical Trials/CTRI/2013/07/003810
CTRI/2013/07/003810Completed未知

Pharmacodynamic interaction study of Emblica officinalis (CAPROS)with clopidogrel and ecosprin in patients with type II diabetes mellitus.

AYUSH0 sites10 target enrollmentStarted: TBDLast updated:
Drugs

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients of either gender between 30-70 yrs, on stable dose of anti-diabetic medication (taking Metformin alone in dose between 1000-2500mg per day or in combination with glimiperide maximum 4 mg per day) as prescribed by the physician over past 8 weeks prior to screening visit and having HbA1c between 6.5-8% were enrolled in the study.

Exclusion Criteria

  • To avoid factors known to affect antiplatelet activity, the following exclusion criteria were applied: severe uncontrolled hyperglycemia, uncontrolled hypertension, cardiac arrhythmia, congestive heart failure, and evidence of hepatic and renal impairment or any other serious chronic disease requiring active treatment. Subjects hypersensitive to the study drugs were also excluded.

Investigators

Sponsor
AYUSH

Similar Trials